1-3 of 3
Rimpei Morita
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Myeloma Cell-Derived Monoclonal Immunoglobulins Trigger IL-1β Secretion Via Inflammasome Activation in Tolerogenic Dendritic Cells

Mariko Ishibashi, Mika Sunakawa-Kii, Yoichi Imai, Hiroki Yamaguchi, Rimpei Morita, Hideto Tamura
Journal: Blood
Blood (2024) 144 (Supplement 1): 1900.
https://doi.org/10.1182/blood-2024-202957
Published: 2024
Journal Articles

Elucidating the Role of Tolerogenic Dendritic Cells in Immune Tolerance and Disease Progression in Multiple Myeloma

Mariko Ishibashi, Mika Sunakawa-Kii, Hiroki Yamaguchi, Rimpei Morita, Hideto Tamura
Journal: Blood
Blood (2023) 142 (Supplement 1): 6596.
https://doi.org/10.1182/blood-2023-179078
Published: 2023
Journal Articles

Serum Soluble CD86, Still a Prognostic Factor in the Novel Agent Era in Multiple Myeloma Patients, Is Produced By Myeloma Cells with High CD86 Variant 3 Expression

Mariko Ishibashi, PhD, Ryosuke Kinoshita, MD, Koiti Inokuchi, MD PhD Prof., Hiroshi Handa, MD PhD, Makoto Sasaki, MD PhD, Norio Komatsu, MD PhD, Yoichi Imai, MD PhD, Norina Hiroike, MD PhD, Junji Tanaka, Sakae Tanosaki, MD PhD, Shigeki Ito, MD, PhD, Mika Sunakawa, MD, Toshio Asayama, MD, Yasuko Kuribayashi-hamada, MD, Rimpei Morita, MD PhD, Hideto Tamura, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4361.
https://doi.org/10.1182/blood-2019-124635
Published: 2019